Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

Abstract

About

This paper, published in 1950, received 1.2k indexed citations. Written by Weijia Kong, Jing Wei, Parveen Abidi, Meihong Lin, Satoru Inaba, Cong Li, Yanling Wang, Zizheng Wang, Shuyi Si and Shukui Wang covering the research area of Oncology, Surgery and Pharmacology. It is primarily cited by scholars working on Pharmacology (788 citations), Molecular Biology (482 citations) and Pharmacology (348 citations). Published in Nature Medicine.

In The Last Decade

doi.org/10.1038/nm1135 →

Countries where authors are citing Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

Since Specialization

Citations

This map shows the geographic impact of Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins more than expected).

Fields of papers citing Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/nm1135.

Explore hit-papers with similar magnitude of impact

Breakdown of academic impact, for the paper The Cross-National Diversity of Corporate Governance: Dimensions and Determinants Breakdown of academic impact, for the paper International Variation in Prostate Cancer Incidence and Mortality Rates Breakdown of academic impact, for the paper Dialkylimidazolium chloroaluminate melts: a new class of room-temperature ionic liquids for electrochemistry, spectroscopy and synthesis Breakdown of academic impact, for the paper Synthetic matrix metalloproteinase-sensitive hydrogels for the conduction of tissue regeneration: Engineering cell-invasion characteristics Breakdown of academic impact, for the paper Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier Breakdown of academic impact, for the paper Media Pendidikan : pengertian, pengembangan, dan pemanfaatannya Breakdown of academic impact, for the paper Biologically active dihydropyrimidones of the Biginelli-type — a literature survey Breakdown of academic impact, for the paper CD4+CD25+ Immunoregulatory T Cells